Stock Market Pioneer$微创机器人-B.HK 该来的终于还是来了。简单分析一下基本面和大环境的利弊：
利：出身好；基石阵容不错（大滑头高瓴又回来了）；认购热情比较高
弊：母公司$微创医疗.HK 今年股价表现非常差；医药 B 新股近期表现惨淡，打新客损失惨重；炒新氛围差，新股上市没有溢价空间
权衡利弊，弊大于利。其实打新主要还是看市场情绪，打新的热情在恢复，孖展表现算是不错，但炒新的热情还是很低，跑了很多老乡，没那么快能忽悠回来。到时候按 50% 顶格回拨，散户手里的货一多，又没人接盘了，大涨的可能性还是不大。2 万多一手，中签率又低，感觉没什么意思。
放弃。
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Like
